Malarone Dosage
Generic name: atovaquone and proguanil
Brand names: Malarone, Malarone Pediatric
Drug class: Antimalarial combinations
Medically reviewed by A Ras MD.
Recommended Adult Dosing
Dosage forms: TAB: 250 mg/100 mg
Malaria prophylaxis
- [1 tab PO qd]
- Start: 1-2 days before exposure; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; D/C 7 days after exposure; see CDC Pre-Travel Malaria Prophylaxis recommendations in Guidelines > Specialties > Infectious Diseases
Malaria tx, uncomplicated
- [4 tabs PO qd x3 days]
- Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; to avoid relapse in acute P. vivax or P. ovale infection, follow up tx w/ primaquine; refer to CDC guidelines
Renal dosing
- [malaria prophylaxis]
- CrCl <30: contraindicated
- HD/PD: not defined
- [malaria tx]
- CrCl >30: no adjustment; CrCl <30: not defined, caution advised
- HD/PD: not defined
Hepatic dosing
- mild-mod impairment: no adjustment; severe impairment: not defined
Recommended Peds Dosing
- Dosage forms: TAB: 62.5 mg/25 mg, 250 mg/100 mg
Malaria prophylaxis
- [*5-8 kg]
- Dose: 31.25 mg/12.5 mg PO qd; Start: 1-2 days before exposure; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; D/C 7 days after exposure; see CDC Pre-Travel Malaria Prophylaxis recommendations in Guidelines > Specialties > Infectious Diseases
- [*9-10 kg]
- Dose: 46.9 mg/18.7 mg PO qd; Start: 1-2 days before exposure; Info: 1 dose = 3/4 of 62.5 mg/25 mg tab; repeat dose if vomiting occurs w/in 30min; give w/ food or milk; D/C 7 days after exposure; see CDC Pre-Travel Malaria Prophylaxis recommendations in Guidelines > Specialties > Infectious Diseases
- [11-20 kg]
- Dose: 62.5 mg/25 mg PO qd; Start: 1-2 days before exposure; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; D/C 7 days after exposure; see CDC Pre-Travel Malaria Prophylaxis recommendations in Guidelines > Specialties > Infectious Diseases
- [21-30 kg]
- Dose: 125 mg/50 mg PO qd; Start: 1-2 days before exposure; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; D/C 7 days after exposure; see CDC Pre-Travel Malaria Prophylaxis recommendations in Guidelines > Specialties > Infectious Diseases
- [31-40 kg]
- Dose: 187.5 mg/75 mg PO qd; Start: 1-2 days before exposure; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; D/C 7 days after exposure; see CDC Pre-Travel Malaria Prophylaxis recommendations in Guidelines > Specialties > Infectious Diseases
- [>41 kg]
- Dose: 250 mg/100 mg PO qd; Start: 1-2 days before exposure; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; D/C 7 days after exposure; see CDC Pre-Travel Malaria Prophylaxis recommendations in Guidelines > Specialties > Infectious Diseases
Malaria tx, uncomplicated
- [5-7 kg]
- Dose: 125 mg/50 mg PO qd x3 days; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; to avoid relapse in acute P. vivax or P. ovale infection, follow up tx w/ primaquine; refer to CDC guidelines
- [8-9 kg]
- Dose: 187.5 mg/75 mg PO qd x3 days; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; to avoid relapse in acute P. vivax or P. ovale infection, follow up tx w/ primaquine; refer to CDC guidelines
- [10-19 kg]
- Dose: 250 mg/100 mg PO qd x3 days; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; to avoid relapse in acute P. vivax or P. ovale infection, follow up tx w/ primaquine; refer to CDC guidelines
- [20-29 kg]
- Dose: 500 mg/200 mg PO qd x3 days; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; to avoid relapse in acute P. vivax or P. ovale infection, follow up tx w/ primaquine; refer to CDC guidelines
- [30-39 kg]
- Dose: 750 mg/300 mg PO qd x3 days; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; to avoid relapse in acute P. vivax or P. ovale infection, follow up tx w/ primaquine; refer to CDC guidelines
- [>40 kg]
- Dose: 1000 mg/400 mg PO qd x3 days; Info: repeat dose if vomiting occurs w/in 30min; give w/ food or milk; to avoid relapse in acute P. vivax or P. ovale infection, follow up tx w/ primaquine; refer to CDC guidelines
Renal dosing
- [malaria prophylaxis]
- CrCl <30: contraindicated
- HD/PD: not defined
- [malaria tx]
- CrCl >30: no adjustment; CrCl <30: not defined, caution advised
- HD/PD: not defined
Hepatic dosing
- mild-mod impairment: no adjustment; severe impairment: not defined
SRC: NLM .